drugset / Trial / NCT01115452

Efficacy of Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity

NCT01115452 ↗

Phase 2 Completed 32 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

An exploratory study investigating the direct application of potassium nitrate (KNO3) solutions of different concentrations in reducing dentine hypersensitivity.

Timeline

Start
2009-09
Primary completion
2009-10
Completion
2009-10

Outcome

Missed primary endpoint

registry p = 0.9347; Adjusted mean difference -0.32 (95% CI -8.14 to 7.50) NCT01115452 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Potassium Nitrate Other / unclassified 2.5 % —
Subject Potassium Nitrate Other / unclassified 5 % —

Indications